ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $330,085 | +19.3% | 60,566 | +46.8% | 0.00% | 0.0% |
| Q2 2023 | $276,794 | -50.8% | 41,251 | -35.3% | 0.00% | -50.0% |
| Q1 2023 | $562,877 | -8.3% | 63,746 | -26.1% | 0.00% | -50.0% |
| Q3 2022 | $614,000 | +19.9% | 86,280 | +36.2% | 0.00% | 0.0% |
| Q2 2022 | $512,000 | -31.3% | 63,340 | +18.0% | 0.00% | -33.3% |
| Q1 2022 | $745,000 | -15.1% | 53,671 | +146.5% | 0.01% | -57.1% |
| Q1 2021 | $877,000 | – | 21,777 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |